Manning & Napier Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Manning & Napier Advisors's ABBV Position: Q3 2026 in Review
Manning & Napier Advisors reduced its AbbVie (ABBV) stake by 0.47% in Q3 2026, selling an estimated $102K and leaving 84,954 shares worth $25.1M. The position accounts for 0.34% of the portfolio, ranked #59.
Manning & Napier Advisors first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Manning & Napier Advisors held 84,954 shares of AbbVie worth $25.1M as of Q3 2026.
- Manning & Napier Advisors sold 398 AbbVie shares in Q3 2026, an estimated $102K.
- AbbVie made up 0.34% of Manning & Napier Advisors's portfolio in Q3 2026, its #59 holding.
- Manning & Napier Advisors first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Manning & Napier Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.